An observational study in Breast Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2024-01-16.
Sponsored by Ohio State University Comprehensive Cancer Center · Observational
This study evaluates Improving the Breast Cancer Care Delivery Model for Sex and Gender Minority (INTENDED for SGM) in identifying the patient, support person and provider barriers to quality care in SGM breast/chest cancer survivors.
PRIMARY OBJECTIVE:
I. To determine the important ways the iCanDecide breast cancer decision aid needs revised for SGM people, and how best to integrate a culturally-relevant tool into clinical practice.
OUTLINE: This is an observational study.
AIM 1: Interview transcripts from SANGRIA study utilized to explore the values, preferences and key considerations for breast cancer treatment decision making in SGM individuals.
AIM 2: Patients are assigned to 1 of 2 groups.
GROUP 1: Cancer survivors participate in a focus group on study.
GROUP 2: Breast cancer clinicians undergo a semi-structured interview on study.
12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.
This study's enrollment of 28 is below the median of 184 across 2,642 observational studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Ohio State University Comprehensive Cancer Center is the lead sponsor of 369 studies on the registry; 81 are open to participants now.
Of its 38 completed or terminated interventional studies of FDA-regulated products, 19 (50%) have results posted.
Counted across the registry records on this site, refreshed daily.
Breast cancer survivors that self-identify as a member of the sex and gender minority community or partner with an individual of the same sex or gender and breast oncology clinicians recruited through Ohio State University Comprehensive Cancer Center.
Inclusion Criteria:
SURVIVORS:
BREAST ONCOLOGY CLINICIANS: Physicians, advanced practice providers, nurses, psychologists and social workers will be eligible if they:
Cancer survivors participate in a focus group on study.
Other: Non-Interventional Study
Breast cancer clinicians undergo a semi-structured interview on study.
Other: Non-Interventional Study
Non-interventional study
Survivor participant feedback, opinions, and preferences for breast cancer care
Data is verbally reported and collected in focus groups
Time frame: At completion of study up to 2 years
Clinician participant reports of experiences, opinions, and knowledge of caring for LGBTQ+ people
Data is verbally reported and collected in interviews
Time frame: At completion of study up to 2 years
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ohio State University Comprehensive Cancer Center